Preetam Shah Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

BCLI Quotes by TradingView

Preetam Shah is EVP, CFO and Treasurer of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 11,600 shares of BCLI, which is worth approximately $25,868. The most recent transaction as insider was on Dec 30, 2020, when has been sold 25,000 shares (Common Stock) at a price of $4.64 per share, resulting in proceeds of $116,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.6K
0% 3M change
0% 12M change
Total Value Held $25,868

Preetam Shah Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 30 2020
SELL
Payment of exercise price or tax liability
$116,000 $4.64 p/Share
25,000 Reduced 68.31%
11,600 Common Stock

Also insider at

CDTX
Cidara Therapeutics, Inc. Healthcare
Chief Financial Officer
PS

Preetam Shah

EVP, CFO and Treasurer
San Diego, CA

Track Institutional and Insider Activities on BCLI

Follow BRAINSTORM CELL THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCLI